This invention provides a compound of formulae (I) or (II) having the structure
1
or a pharmaceutically acceptable salt thereof which are useful for the treatment of the inflammatory component of diseases and are particularly useful in treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, type II diabetes, and autoimmune diseases such as multiple sclerosis and rheumatiod arthritis.
A binap-ligated copper dimer has been heterogenized on a pillar-layered MOF surface for the first time using a hydroxamic acid linker. This MOF-supported dimeric copper photocatalyst demonstrates much higher activity and recyclability than its homogeneous counterparts in intra- and intermolecular radicalreactions of N-acyloxy imidates and O-acyl oximes.